Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Md Arifur Rahman & Md Sayeedul Islam. (2021) Early approval of COVID-19 vaccines: Pros and cons. Human Vaccines & Immunotherapeutics 17:10, pages 3288-3296.
Read now
Read now
Ina Chen, Michael Y. Chen, S. Peter Goedegebuure & William E. Gillanders. (2021) Challenges targeting cancer neoantigens in 2021: a systematic literature review. Expert Review of Vaccines 20:7, pages 827-837.
Read now
Read now
Franz Zemp, Jahanara Rajwani & Douglas J. Mahoney. (2018) Rhabdoviruses as vaccine platforms for infectious disease and cancer. Biotechnology and Genetic Engineering Reviews 34:1, pages 122-138.
Read now
Read now
Satoshi Wada, Erica Yada, Junya Ohtake & Tetsuro Sasada. (2017) Personalized peptide vaccines for cancer therapy: current progress and state of the art. Expert Review of Precision Medicine and Drug Development 2:6, pages 371-381.
Read now
Read now
David Gfeller, Michal Bassani-Sternberg, Julien Schmidt & Immanuel F. Luescher. (2016) Current tools for predicting cancer-specific T cell immunity. OncoImmunology 5:7.
Read now
Read now
Jonathan Pol, Norma Bloy, Aitziber Buqué, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Peptide-based anticancer vaccines. OncoImmunology 4:4.
Read now
Read now
Drew Weissman. (2015) mRNA transcript therapy. Expert Review of Vaccines 14:2, pages 265-281.
Read now
Read now
Daphné Benteyn, Carlo Heirman, Aude Bonehill, Kris Thielemans & Karine Breckpot. (2015) mRNA-based dendritic cell vaccines. Expert Review of Vaccines 14:2, pages 161-176.
Read now
Read now
Sebastian Boegel, Martin Löwer, Thomas Bukur, Ugur Sahin & John C Castle. (2014) A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines. OncoImmunology 3:8.
Read now
Read now
Jelle J Lindenberg, Rieneke van de Ven, Dinja Oosterhoff, Claudia C Sombroek, Sinéad M Lougheed, Anita GM Stam, Hans JPM Koenen, Alfons JM van den Eertwegh, Rik J Scheper & Tanja D de Gruijl. (2014) Induction of dendritic cell maturation in the skin microenvironment by soluble factors derived from colon carcinoma. Human Vaccines & Immunotherapeutics 10:6, pages 1622-1632.
Read now
Read now
Michaela Semeraro, Erika Vacchelli, Alexander Eggermont , Jerome Galon, L Zitvogel, G Kroemer & Lorenzo Galluzzi. (2013) Trial Watch: Lenalidomide-based immunochemotherapy. OncoImmunology 2:11.
Read now
Read now
Debraj GuhaThakurta, Nadeem A Sheikh, T Craig Meagher, Simon Letarte & James B Trager. (2013) Applications of systems biology in cancer immunotherapy: from target discovery to biomarkers of clinical outcome. Expert Review of Clinical Pharmacology 6:4, pages 387-401.
Read now
Read now
Articles from other publishers (34)
Iker Malaina, Lorena Gonzalez-Melero, Luis Martínez, Aiala Salvador, Ana Sanchez-Diez, Aintzane Asumendi, Javier Margareto, Jose Carrasco-Pujante, Leire Legarreta, María Asunción García, Martín Blas Pérez-Pinilla, Rosa Izu, Ildefonso Martínez de la Fuente, Manoli Igartua, Santos Alonso, Rosa Maria Hernandez & María Dolores Boyano. (2023) Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design. International Journal of Molecular Sciences 24:10, pages 9024.
Crossref
Crossref
Lijin Li, Xiuli Zhang, Xiaoli Wang, Samuel W. Kim, John M. Herndon, Michelle K. Becker-Hapak, Beatriz M. Carreno, Nancy B. Myers, Mark A. Sturmoski, Michael D. McLellan, Christopher A. Miller, Tanner M. Johanns, Benjamin R. Tan, Gavin P. Dunn, Timothy P. Fleming, Ted H. Hansen, S. Peter Goedegebuure & William E. Gillanders. (2021) Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation. Genome Medicine 13:1.
Crossref
Crossref
Lara S. Costard, Ryan R. Hosn, Harumi Ramanayake, Fergal J. O'Brien & Caroline M. Curtin. (2021) Influences of the 3D microenvironment on cancer cell behaviour and treatment responsiveness: A recent update on lung, breast and prostate cancer models. Acta Biomaterialia 132, pages 360-378.
Crossref
Crossref
A. Farias, A. Soto, F. Puttur, C. J. Goldin, S. Sosa, C. Gil, F. A. Goldbaum & P. M. Berguer. (2021) A TLR4 agonist improves immune checkpoint blockade treatment by increasing the ratio of effector to regulatory cells within the tumor microenvironment. Scientific Reports 11:1.
Crossref
Crossref
Lin Qin, Huilin Zhang, Yang Zhou, Channakeshava Sokke Umeshappa & Huile Gao. (2021) Nanovaccine‐Based Strategies to Overcome Challenges in the Whole Vaccination Cascade for Tumor Immunotherapy. Small 17:28, pages 2006000.
Crossref
Crossref
Maarten K. Nijen Twilhaar, Lucas Czentner, Cornelus F. van Nostrum, Gert Storm & Joke M. M. den Haan. (2021) Mimicking Pathogens to Augment the Potency of Liposomal Cancer Vaccines. Pharmaceutics 13:7, pages 954.
Crossref
Crossref
Hannah E Olsen, Geoffrey M Lynn, Pablo A Valdes, Christian D Cerecedo Lopez, Andrew S Ishizuka, Omar Arnaout, W Linda Bi, Pier Paolo Peruzzi, E Antonio Chiocca, Gregory K Friedman & Joshua D Bernstock. (2021) Therapeutic cancer vaccines for pediatric malignancies: advances, challenges, and emerging technologies. Neuro-Oncology Advances 3:1.
Crossref
Crossref
Amma F. Agyemang & Kunle O. Odunsi. 2021. Overcoming Ovarian Cancer Chemoresistance. Overcoming Ovarian Cancer Chemoresistance
79
96
.
Vanessa Acebes-Fernández, Alicia Landeira-Viñuela, Pablo Juanes-Velasco, Angela-Patricia Hernández, Andrea Otazo-Perez, Raúl Manzano-Román, Rafael Gongora & Manuel Fuentes. (2020) Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers. Nanomaterials 10:7, pages 1274.
Crossref
Crossref
Iker Malaina, Leire Legarreta, Mª Dolores Boyano, Santos Alonso, Ildefonso M. De la Fuente & Luis Martinez. 2020. Bioinformatics and Biomedical Engineering. Bioinformatics and Biomedical Engineering
40
48
.
Miao Peng, Yongzhen Mo, Yian Wang, Pan Wu, Yijie Zhang, Fang Xiong, Can Guo, Xu Wu, Yong Li, Xiaoling Li, Guiyuan Li, Wei Xiong & Zhaoyang Zeng. (2019) Neoantigen vaccine: an emerging tumor immunotherapy. Molecular Cancer 18:1.
Crossref
Crossref
Chizu Nonomura, Masaki Otsuka, Ryota Kondou, Akira Iizuka, Haruo Miyata, Tadashi Ashizawa, Naoki Sakura, Shusuke Yoshikawa, Yoshio Kiyohara, Keiichi Ohshima, Kenichi Urakami, Takeshi Nagashima, Sumiko Ohnami, Masatoshi Kusuhara, Koichi Mitsuya, Nakamasa Hayashi, Yoko Nakasu, Tohru Mochizuki, Ken Yamaguchi & Yasuto Akiyama. (2019) Identification of a neoantigen epitope in a melanoma patient with good response to anti-PD-1 antibody therapy. Immunology Letters.
Crossref
Crossref
Karim Vermaelen. (2019) Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses. Frontiers in Immunology 10.
Crossref
Crossref
Girja S. Shukla, Yu-Jing Sun, Stephanie C. Pero, Giselle S. Sholler & David N. Krag. (2018) Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses. Journal of Immunological Methods 460, pages 51-62.
Crossref
Crossref
Özlem Türeci, Martin Löwer, Barbara Schrörs, Maren Lang, Arbel Tadmor & Ugur Sahin. (2018) Challenges towards the realization of individualized cancer vaccines. Nature Biomedical Engineering 2:8, pages 566-569.
Crossref
Crossref
David Gfeller & Michal Bassani-Sternberg. (2018) Predicting Antigen Presentation—What Could We Learn From a Million Peptides?. Frontiers in Immunology 9.
Crossref
Crossref
Amanda R. Aldous & Jesse Z. Dong. (2018) Personalized neoantigen vaccines: A new approach to cancer immunotherapy. Bioorganic & Medicinal Chemistry 26:10, pages 2842-2849.
Crossref
Crossref
Matthew M. Gubin. (2017) Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology Keystone Symposia Meeting Summary. Cancer Immunology Research 5:6, pages 434-438.
Crossref
Crossref
Jeff Kamta, Maher Chaar, Anusha Ande, Deborah A. Altomare & Sihem Ait-Oudhia. (2017) Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches. Frontiers in Oncology 7.
Crossref
Crossref
Suneetha Amara & Venkataswarup Tiriveedhi. (2017) The Five Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy. International Journal of Molecular Sciences 18:3, pages 650.
Crossref
Crossref
Xiuli Zhang, Piyush K. Sharma, S. Peter Goedegebuure & William E. Gillanders. (2017) Personalized cancer vaccines: Targeting the cancer mutanome. Vaccine 35:7, pages 1094-1100.
Crossref
Crossref
Ton N Schumacher & Nir Hacohen. (2016) Neoantigens encoded in the cancer genome. Current Opinion in Immunology 41, pages 98-103.
Crossref
Crossref
Masatoshi Hirayama & Yasuharu Nishimura. (2016) The present status and future prospects of peptide-based cancer vaccines. International Immunology 28:7, pages 319-328.
Crossref
Crossref
Sandra Van Lint, Dries Renmans, Katrijn Broos, Lode Goethals, Sarah Maenhout, Daphné Benteyn, Cleo Goyvaerts, Stephanie Du Four, Kevin Van der Jeught, Lukasz Bialkowski, Véronique Flamand, Carlo Heirman, Kris Thielemans & Karine Breckpot. (2016) Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells. Cancer Immunology Research 4:2, pages 146-156.
Crossref
Crossref
Zhenlong Ye, Zhong Li, Huajun Jin & Qijun Qian. 2016. Progress in Cancer Immunotherapy. Progress in Cancer Immunotherapy
139
167
.
Jurjen M. Ruben, Hetty J. Bontkes, Theresia M. Westers, Erik Hooijberg, Gert J. Ossenkoppele, Tanja D. de Gruijl & Arjan A. van de Loosdrecht. (2015) Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigen. Cancer Immunology, Immunotherapy 64:11, pages 1419-1427.
Crossref
Crossref
Cornelis J.M. Melief, Thorbald van Hall, Ramon Arens, Ferry Ossendorp & Sjoerd H. van der Burg. (2015) Therapeutic cancer vaccines. Journal of Clinical Investigation 125:9, pages 3401-3412.
Crossref
Crossref
Alexios Matikas & Dimitrios Mavroudis. (2015) Beyond CTLA-4: novel immunotherapy strategies for metastatic melanoma. Future Oncology 11:6, pages 997-1009.
Crossref
Crossref
Ugur Sahin, Katalin Karikó & Özlem Türeci. (2014) mRNA-based therapeutics — developing a new class of drugs. Nature Reviews Drug Discovery 13:10, pages 759-780.
Crossref
Crossref
Sandra Van Lint, Sofie Wilgenhof, Carlo Heirman, Jurgen Corthals, Karine Breckpot, Aude Bonehill, Bart Neyns & Kris Thielemans. (2014) Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula. Cancer Immunology, Immunotherapy 63:9, pages 959-967.
Crossref
Crossref
Brian D. Lichty, Caroline J. Breitbach, David F. Stojdl & John C. Bell. (2014) Going viral with cancer immunotherapy. Nature Reviews Cancer 14:8, pages 559-567.
Crossref
Crossref
Karl-Josef Kallen & Andreas Theß. (2013) A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs. Therapeutic Advances in Vaccines 2:1, pages 10-31.
Crossref
Crossref
J. Müller-Berghaus, P. Volkers, J. Scherer & K. Cichutek. (2013) Besonderheiten bei der Regulierung biologischer Arzneimittel in der individualisierten MedizinSpecial considerations for the regulation of biological medicinal products in individualised medicine. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 56:11, pages 1538-1544.
Crossref
Crossref
Robert H Vonderheide & Katherine L Nathanson. (2013) Immunotherapy at Large: The road to personalized cancer vaccines. Nature Medicine 19:9, pages 1098-1100.
Crossref
Crossref